1/27
08:04 am
vtvt
vTv Therapeutics (NASDAQ:VTVT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $49.00 price target on the stock, up previously from $40.00.
Low
Report
vTv Therapeutics (NASDAQ:VTVT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $49.00 price target on the stock, up previously from $40.00.
1/27
06:06 am
vtvt
Rating for VTVT
Low
Report
Rating for VTVT
1/23
04:45 am
vtvt
Rating for VTVT
Low
Report
Rating for VTVT
1/23
04:45 am
vtvt
Rating for VTVT
Low
Report
Rating for VTVT
1/22
04:07 pm
vtvt
vTv Therapeutics initiated with a Buy at Roth Capital
Medium
Report
vTv Therapeutics initiated with a Buy at Roth Capital
1/22
04:07 pm
vtvt
vTv Therapeutics initiated with a Buy at Roth Capital
Medium
Report
vTv Therapeutics initiated with a Buy at Roth Capital
12/19
09:09 am
vtvt
vTv Therapeutics (NASDAQ:VTVT) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
vTv Therapeutics (NASDAQ:VTVT) had its "buy" rating reaffirmed by analysts at HC Wainwright.